Search results
Drugmaker Servier loses EU court fight over pay-for-delay deals
Reuters via Yahoo Singapore Finance· 1 month agoBy Foo Yun Chee BRUSSELS (Reuters) -French drugmaker Servier on Thursday lost its court battle...
Amblin & Bad Robot Board PGA Health Insurance Initiative; “Just The Beginning,” Guild Bosses Declare...
Deadline via Yahoo Singapore Finance· 2 months agoThe Producers Guild of America’s ongoing efforts to ensure health insurance benefits for all its...
US Supreme Court spurns Sanofi appeal to revive EpiPen suit against Viatris
Reuters via Yahoo Singapore Finance· 1 year agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive...
Viatris Inc's Dividend Analysis
GuruFocus.com via Yahoo Singapore Finance· 2 months agoViatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-23. As...
Viatris Inc. (VTRS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic Shifts and ...
GuruFocus.com via Yahoo Singapore Finance· 3 months agoRevenue: Reported at $3.66 billion, slightly below the estimate of $3.69 billion. Net Income: U.S....
Universal Proxy Put to Test at Disney: Hear from Morrow Sodali’s Michael Verrechia at Tulane
IPO-Edge.com via Yahoo Singapore Finance· 4 months agoIPO Edge sister platform CorpGov hosted a fireside chat with Michael Verrechia, Partner and Managing...
Black women-owned firm targeted by conservative activist for grant program: 'We are not scared'
Yahoo News· 12 months agoFearless Fund, an Atlanta-based venture capital firm, was sued last week for discrimination for...
Regeneron preliminary Q4 US sales of Eylea below expectations
Reuters via Yahoo Singapore Finance· 7 months agoShares of Regeneron were down over 2% in premarket trading. Eylea, jointly developed with Bayer AG,...
If You Invested $1000 in Abbott a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Singapore Finance· 8 months agoHow much a stock's price changes over time is important for most investors, since price performance...
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Reuters via Yahoo Singapore Finance· 4 months ago(Reuters) -Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their...